+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Poultry Vaccine Market by Disease Type, Technology, Dosage Form - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968978
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Poultry Vaccine Market grew from USD 2.07 billion in 2023 to USD 2.23 billion in 2024. It is expected to continue growing at a CAGR of 7.86%, reaching USD 3.51 billion by 2030.

The poultry vaccine market is defined by its role in preventing and controlling infectious diseases within poultry populations, which is critical for ensuring animal health, public safety, and profitability in the poultry industry. Necessity arises from the high susceptibility of poultry to diseases like avian influenza and Newcastle disease, which can result in severe economic losses. Vaccines are primarily applied through water, sprays, or injections, with their end-uses spanning across broilers, layers, breeders, and hatcheries. The market has experienced growth due to increasing poultry consumption, which drives demand for quality poultry products, necessitating robust vaccination regimes. Key growth factors include advancements in vaccine technologies, such as recombinant vaccine development, enhanced governmental support for animal health, and growing awareness about zoonotic diseases.

Potential opportunities lie in expanding vaccination coverage in emerging markets, where poultry production is rapidly increasing. Companies can focus on developing vaccines that provide broader protection and are easier to administer. Additionally, innovations in monitoring and diagnostic tools, such as rapid on-farm disease detection kits, can bolster vaccine efficacy and uptake. However, limitations persist, including high costs of vaccine development and production, lack of uniform regulations across countries, and sometimes inadequate infrastructure in rural areas for effective vaccine delivery. Challenges also encompass variability in vaccine response due to genetic differences among poultry breeds and issues related to vaccine storage and handling.

Areas ripe for innovation include the development of thermostable vaccines that do not require cold chain storage, digital platforms to track vaccination schedules and monitor health outcomes, and the adoption of biotechnological advances like CRISPR for creating novel vaccines. Research into multi-valent vaccines that cover multiple diseases could significantly reduce increase ease of administration. The market is dynamic, with numerous opportunities for stakeholders to innovate and capture emerging demands by aligning with global health trends and regulatory frameworks, ultimately enhancing growth prospects.

Understanding Market Dynamics in the Poultry Vaccine Market

The Poultry Vaccine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidence of animal diseases
    • Surge in awareness on animal vaccination globally
    • Rising consumption of poultry protein worldwide
  • Market Restraints
    • Availability of counterfeit medicine
  • Market Opportunities
    • Technological advancements for vaccine manufacturing
    • Ongoing aim to increase food safety coupled with favorable government initiatives
  • Market Challenges
    • Strict regulatory approval and compliance concerns
    • High cost of veterinary testing and services

Exploring Porter’s Five Forces for the Poultry Vaccine Market

Porter’s Five Forces framework further strengthens the insights of the Poultry Vaccine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Poultry Vaccine Market

External macro-environmental factors deeply influence the performance of the Poultry Vaccine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Poultry Vaccine Market

The Poultry Vaccine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Poultry Vaccine Market

The Poultry Vaccine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Poultry Vaccine Market

The Poultry Vaccine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Poultry Vaccine Market, highlighting leading vendors and their innovative profiles. These include Adnimalis Group, Anicon Labor GmbH, Bayer AG, Biovac Ltd., Biovet Private Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Life Circle Nutrition AG, Medicavet, Merck & Co., Inc., Nutriment Health Pty. Ltd., Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Virbac Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Poultry Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Disease Type
    • Infectious Bronchitis
    • Marek’s Disease
    • New Castle Disease
  • Technology
    • Inactivated
    • Live Attenuated Vaccines
    • Recombinant
    • Toxoid
  • Dosage Form
    • Freeze Dried Vaccines
    • Liquid
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of animal diseases
5.1.1.2. Surge in awareness on animal vaccination globally
5.1.1.3. Rising consumption of poultry protein worldwide
5.1.2. Restraints
5.1.2.1. Availability of counterfeit medicine
5.1.3. Opportunities
5.1.3.1. Technological advancements for vaccine manufacturing
5.1.3.2. Ongoing aim to increase food safety coupled with favorable government initiatives
5.1.4. Challenges
5.1.4.1. Strict regulatory approval and compliance concerns
5.1.4.2. High cost of veterinary testing and services
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Poultry Vaccine Market, by Disease Type
6.1. Introduction
6.2. Infectious Bronchitis
6.3. Marek’s Disease
6.4. New Castle Disease
7. Poultry Vaccine Market, by Technology
7.1. Introduction
7.2. Inactivated
7.3. Live Attenuated Vaccines
7.4. Recombinant
7.5. Toxoid
8. Poultry Vaccine Market, by Dosage Form
8.1. Introduction
8.2. Freeze Dried Vaccines
8.3. Liquid
9. Americas Poultry Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Poultry Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Poultry Vaccine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. POULTRY VACCINE MARKET RESEARCH PROCESS
FIGURE 2. POULTRY VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. POULTRY VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. POULTRY VACCINE MARKET DYNAMICS
TABLE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 29. CANADA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. CANADA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 32. MEXICO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. MEXICO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. CHINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. CHINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 49. INDIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. INDIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. JAPAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. JAPAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 73. THAILAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. THAILAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. EGYPT POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. EGYPT POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 89. FINLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. FINLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 92. FRANCE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. FRANCE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. GERMANY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. ITALY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. ITALY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 110. NORWAY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. NORWAY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 113. POLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. POLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. QATAR POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. QATAR POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. SPAIN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. SPAIN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. TURKEY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. TURKEY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 146. POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Poultry Vaccine Market, which are profiled in this report, include:
  • Adnimalis Group
  • Anicon Labor GmbH
  • Bayer AG
  • Biovac Ltd.
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Life Circle Nutrition AG
  • Medicavet
  • Merck & Co., Inc.
  • Nutriment Health Pty. Ltd.
  • Phibro Animal Health Corporation
  • Qilu Animal Health Products Co., Ltd.
  • Virbac Group
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information